Frank Mullery

A Senior Executive with 20 years of experience, primarily in the healthcare and pharmaceutical sectors, with a reputation of success in identifying and executing on unique business opportunities. Previously, I held the role of President of Mylan Institutional where I established Mylan as a key player in the Injectable Market by growing revenues over 20% in 2018 to $1B. Launched Mylan's first Biosimilar (Fulphila) in the US, established key partnerships with GPO's/IDN's/ and wholesale partners, and launched over 20 injectable products last year. I am a proven strategic thinker and problem solver who enjoys competing in the marketplace each day, taking on business challenges and working with teams to identify areas of opportunity. I am in a relentless pursuit to get better each day and believe in order to build something special it takes commitment day in and day out. In my experience at Mylan over 7 years, I have served the company in several capacities of increasing responsibility. Prior to my last role, I served as Chief Financial Officer of North America where I successfully lead the company's largest region. I began my career at Mylan as CFO of Mylan Pharmaceuticals Inc, the company's flagship generics division in the U.S. Focused on oral solid dose products. Before joining Mylan, I worked for Teva Pharmaceuticals and Viropharma Inc. At Teva, I served the company in various financial roles including leading the planning and analysis function for the U.S. While at Viropharma, I worked in both the commercial and financial groups most notably leading the commercial operations for the company's first biologic product Cynrize. I earned my Executive MBA from Villanova University and bachelors degree in Accounting from King's College.